Sana Biotechnology: Fundraising Triggers Major Sell-Off, I'm Still Intrigued (NASDAQ:SANA)

Sana Biotechnology's allogeneic HIP technology achieved a first in T1D, showing insulin production and without immunosuppression. Learn more on SANA stock here.